Amgen Inc.
Amgen Inc. (AMGN) Revenue
Annual & quarterly revenue history · segment & region breakdown
AMGN · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsAmgen Inc. trailing twelve-month (TTM) revenue is $37.24B, an increase of 9.92% year-over-year from $36.74B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $36.74B | +$3.32B | +9.92% |
| 2024-12-31 | $33.42B | +$5.23B | +18.57% |
| 2023-12-31 | $28.19B | +$1.87B | +7.09% |
| 2022-12-31 | $26.32B | +$0.34B | +1.32% |
| 2021-12-31 | $25.98B | +$0.56B | +2.18% |
| 2020-12-31 | $25.42B | +$2.06B | +8.83% |
| 2019-12-31 | $23.36B | -$0.39B | -1.62% |
| 2018-12-31 | $23.75B | +$0.90B | +3.93% |
| 2017-12-31 | $22.85B | -$0.14B | -0.62% |
| 2016-12-31 | $22.99B | +$1.33B | +6.14% |
Compare revenue vs peers
Drug Manufacturers - GeneralCompare AMGN revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Amgen Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Amgen Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Amgen Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
AMGN revenue · 4 questionsAMGN's trailing twelve-month (TTM) revenue is $37.24B. That is an increase of 9.92% year-over-year from $36.74B in FY2025.
▸ Source: FMP · Amgen Inc. SEC filings · GAAP · Amgen Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026